Diuretics, hypokalemia, and cardiac arrhythmia: a 20-year controversy.
作者信息
Papademetriou Vasilios
出版信息
J Clin Hypertens (Greenwich). 2006 Feb;8(2):86-92. doi: 10.1111/j.1524-6175.2005.04722.x.
Abstract
摘要
相似文献
1
Diuretics, hypokalemia, and cardiac arrhythmia: a 20-year controversy.利尿剂、低钾血症与心律失常：一场持续20年的争论。
J Clin Hypertens (Greenwich). 2006 Feb;8(2):86-92. doi: 10.1111/j.1524-6175.2005.04722.x.
2
Diuretics, hypokalemia, and cardiac arrhythmias: a critical analysis.
Am Heart J. 1986 Jun;111(6):1217-24. doi: 10.1016/0002-8703(86)90041-4.
3
[Cardiovascular risk of diuretics in the treatment of arterial hypertension].[利尿剂在治疗动脉高血压中的心血管风险]
Nephrologie. 1987;8(5):247-52.
4
Mild hypertension, diuretics, and cardiac arrhythmias: consensus amid controversy?轻度高血压、利尿剂与心律失常：争议中的共识？
Am Heart J. 1988 Jul;116(1 Pt 1):216-21. doi: 10.1016/0002-8703(88)90279-7.
5
Diuretics in hypertension: clinical experiences.
Eur Heart J. 1992 Dec;13 Suppl G:92-5. doi: 10.1093/eurheartj/13.suppl_g.92.
6
Diuretics, hypokalaemia and arrhythmias in hypertensive patients: still an unresolved problem.高血压患者中的利尿剂、低钾血症与心律失常：仍是一个未解决的问题。
J Hypertens Suppl. 1987 Aug;5(3):S51-5.
7
Potassium loss, ventricular irritability, and the risk of sudden death in hypertensive patients.高血压患者的钾流失、心室易激惹性与猝死风险
Drugs. 1986;31 Suppl 4:78-84. doi: 10.2165/00003495-198600314-00010.
8
Diuretic-induced hypokalemia and cardiac arrhythmias.
Am J Cardiol. 1986 Jul 31;58(2):5A-10A. doi: 10.1016/0002-9149(86)90875-1.
9
Magnesium and potassium. Inter-relationships in cardiac disorders.镁与钾。心脏疾病中的相互关系。
Drugs. 1986;31 Suppl 4:121-31. doi: 10.2165/00003495-198600314-00015.
10
[Hypertension and arrhythmia].[高血压与心律失常]
Vnitr Lek. 1988 Aug;34(8):813-8.
引用本文的文献
1
The Calm Before the Storm: A Pheochromocytoma Case Report.暴风雨前的平静：一例嗜铬细胞瘤病例报告
Cureus. 2023 Oct 12;15(10):e46915. doi: 10.7759/cureus.46915. eCollection 2023 Oct.
2
Hypokalemia-Induced Arrhythmias and Heart Failure: New Insights and Implications for Therapy.低钾血症诱发的心律失常与心力衰竭：新见解及治疗意义
Front Physiol. 2018 Nov 7;9:1500. doi: 10.3389/fphys.2018.01500. eCollection 2018.
3
Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry.欧洲和非洲血统队列中SNP与9-血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂以及SNP与噻嗪类利尿剂相互作用对血清钾影响的全基因组荟萃分析。
Pharmacogenomics J. 2019 Feb;19(1):97-108. doi: 10.1038/s41397-018-0021-9. Epub 2018 Jun 1.
4
Hypokalemia: a clinical update.低钾血症：临床最新进展
Endocr Connect. 2018 Apr;7(4):R135-R146. doi: 10.1530/EC-18-0109. Epub 2018 Mar 14.
5
Pain medication and long QT syndrome.止痛药物与长QT综合征
Korean J Pain. 2018 Jan;31(1):3-9. doi: 10.3344/kjp.2018.31.1.3. Epub 2018 Jan 2.
6
Diuretic activity of the aqueous crude extract and hot tea infusion of (Baker f.) Cufod. leaves in rats.（贝克氏变种）库福氏叶子的水粗提物和热茶浸剂对大鼠的利尿活性。
J Exp Pharmacol. 2017 Jun 21;9:73-80. doi: 10.2147/JEP.S133778. eCollection 2017.
7
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.降压和降脂治疗预防心脏病发作试验中治疗高血压患者中出现的低钾血症和高钾血症的临床意义。
Hypertension. 2012 May;59(5):926-33. doi: 10.1161/HYPERTENSIONAHA.111.180554. Epub 2012 Mar 19.
8
QTc pseudoprolongation and hypokalemia-induced T-U fusion: the authors reply.
Intern Emerg Med. 2012 Apr;7(2):195. doi: 10.1007/s11739-011-0747-8. Epub 2011 Dec 11.
9
Acquired long QT interval: a case series of multifactorial QT prolongation.获得性长 QT 间期：多因素 QT 延长的病例系列。
Clin Cardiol. 2011 Sep;34(9):577-82. doi: 10.1002/clc.20945. Epub 2011 Sep 1.
本文引用的文献
1
Diuretics and new onset diabetes: is it a problem?利尿剂与新发糖尿病：这是个问题吗？
J Hypertens. 2005 Mar;23(3):666-8; author reply 668-9. doi: 10.1097/01.hjh.0000160227.39963.3e.
2
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.全国高血压防治联合委员会第七次报告：预防、检测、评估及治疗
Hypertension. 2003 Dec;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2. Epub 2003 Dec 1.
3
Chlorothiazide in hypertensive and normotensive patients.氯噻嗪在高血压和血压正常患者中的应用。
Ann N Y Acad Sci. 1958 Feb 3;71(4):450-5. doi: 10.1111/j.1749-6632.1958.tb46773.x.
4
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.作为一线药物使用的各种抗高血压疗法相关的健康结局：一项网状Meta分析。
JAMA. 2003 May 21;289(19):2534-44. doi: 10.1001/jama.289.19.2534.
5
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.心血管终点维拉帕米控制起效研究（CONVINCE）试验的主要结果。
JAMA. 2003;289(16):2073-82. doi: 10.1001/jama.289.16.2073.
6
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.特定年龄的正常血压与血管性死亡率的相关性：对61项前瞻性研究中100万成年人个体数据的荟萃分析
Lancet. 2002 Dec 14;360(9349):1903-13. doi: 10.1016/s0140-6736(02)11911-8.
7
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).高危高血压患者随机接受血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗的主要结局：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）
JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981.
8
Cardiovascular protection and blood pressure reduction: a meta-analysis.心血管保护与血压降低：一项荟萃分析。
Lancet. 2001 Oct 20;358(9290):1305-15. doi: 10.1016/S0140-6736(01)06411-X.
9
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.血管紧张素转换酶抑制剂、钙拮抗剂及其他降压药物的作用：前瞻性设计的随机试验综述结果。降压治疗试验协作组
Lancet. 2000 Dec 9;356(9246):1955-64. doi: 10.1016/s0140-6736(00)03307-9.
10
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).国际硝苯地平控释片研究（INSIGHT）：长效钙通道阻滞剂或利尿剂双盲治疗患者的发病率和死亡率——高血压治疗以干预为目标
Lancet. 2000 Jul 29;356(9227):366-72. doi: 10.1016/S0140-6736(00)02527-7.
Zotero 插件